9,784 results on '"Gressner, Axel"'
Search Results
52. X
53. Y
54. J
55. Potential novel biomarkers for monitoring the fibrogenic process in liver
56. Increased serum xylosyltransferase activity in patients with liver fibrosis
57. Impact of quality control accepted inter-laboratory variations on calculated Fibrotest/Actitest scores for the non-invasive biochemical assessment of liver fibrosis
58. Evaluation of serum percent trisialotransferrin as potential predictive biomarker of hepatocellular dedifferentiation in chronic liver disease
59. Questioning the role of actinfree Gc-Globulin as actin scavenger in neurodegenerative central nervous system disease: Relationship to S-100B levels and blood–brain barrier function
60. 5 Gastrointestinalsystem
61. Platelet-derived growth factor isoform expression in carbon tetrachloride-induced chronic liver injury
62. Transforming growth factor β1 gene variants increase transcription and are associated with liver cirrhosis in Chinese
63. Evaluation of a novel reverse-hybridization StripAssay for typing DNA variants useful in diagnosis of adult-type hypolactasia
64. Gc-globulin (vitamin D binding protein) is synthesized and secreted by hepatocytes and internalized by hepatic stellate cells through Ca 2+-dependent interaction with the megalin/gp330 receptor
65. Pitfalls in LightCycler diagnosis of the single-nucleotide polymorphism 13.9 kb upstream of the lactase gene that is associated with adult-type hypolactasia
66. IFN-γ abrogates profibrogenic TGF-β signaling in liver by targeting expression of inhibitory and receptor Smads
67. Saliva collection method affects predictability of serum cortisol
68. Biomarkers of liver fibrosis: Clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests
69. High prevalence of increased trisialotransferrin concentrations in patients with anorexia nervosa: Implications for determination of carbohydrate-deficient transferrin
70. Heterophile Antikörper, fehlende Kommunikation und das diagnostische Dilemma
71. Cryopreservation of hepatic stellate cells
72. Elevation of Nε-(carboxymethyl)lysine-modified advanced glycation end products in chronic liver disease is an indicator of liver cirrhosis
73. Argininosuccinate lyase deficiency (ASL) and carbohydrate-deficient transferrin (CDT): Experience with four independent CDT analysis methods — misleading results given by the %CDT TIA assay
74. Primary biliary cirrhosis is not a clinical condition for increased carbohydrate-deficient transferrin: Experience with four independent CDT analysis methods
75. Genomic locus and promoter region of rat Smad7, an important antagonist of TGFβ signaling
76. Herausgeber und Autoren
77. Leber und Gallenblase/-wege
78. Molecular and functional aspects of latent transforming growth factor-β binding protein: just a masking protein?
79. The cell biology of liver fibrogenesis – an imbalance of proliferation, growth arrest and apoptosis of myofibroblasts
80. Identification of paraxanthine as the most potent caffeine-derived inhibitor of connective tissue growth factor expression in liver parenchymal cells
81. Elevated concentrations of 15-deoxy-Δ12,14-prostaglandin J2 in chronic liver disease propose therapeutic trials with peroxisome proliferator activated receptor γ-inducing drugs
82. Altered factor VII activating protease expression in murine hepatic fibrosis and its influence on hepatic stellate cells
83. Isolation and Culture of Hepatic Stellate Cells
84. Leber und Gallenblase/-wege
85. Expression patterns of PDGF-A, -B, -C and -D and the PDGF-receptors α and β in activated rat hepatic stellate cells (HSC)
86. Patients with acute on chronic liver failure display ‘sepsis-like’ immune paralysis
87. Activation of TGF-β within cultured hepatocytes and in liver injury leads to intracrine signaling with expression of connective tissue growth factor
88. Intracrine signalling of activin A in hepatocytes upregulates connective tissue growth factor (CTGF/CCN2) expression
89. Connective tissue growth factor: a fibrogenic master switch in fibrotic liver diseases
90. Changing the pathogenetic roadmap of liver fibrosis? Where did it start; where will it go?
91. Maternal factor V Leiden mutation is associated with HELLP syndrome in Caucasian women
92. Alternative antibody for the detection of CA19-9 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® GI Monitor assay on the UniCel® DxI 800 Immunoassay System
93. Alternative antibody for the detection of CA15-3 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® BR Monitor assay on the UniCel® DxI 800 Immunoassay System
94. Alternative antibody for the detection of CA125 antigen: a European multicenter study for the evaluation of the analytical and clinical performance of the Access® OV Monitor assay on the UniCel® DxI 800 Immunoassay System
95. Evaluation of hepatotropic targeting properties of allogenic and xenogenic erythrocyte ghosts in normal and liver-injured rats
96. Decreased Plasminogen Activator Inhibitor and Tissue Metalloproteinase Inhibitor Expression May Promote Increased Metalloproteinase Activity with Increasing Duration of Human Atrial Fibrillation
97. Immortal hepatic stellate cell lines: useful tools to study hepatic stellate cell biology and function?
98. Insulin Resistance in Liver Cirrhosis Is Not Associated With Circulating Retinol-Binding Protein 4
99. Ito Cells Are Liver-Resident Antigen-Presenting Cells for Activating T Cell Responses
100. Relation of haemofilter type to venous catheter resistance is crucial for filtration performance and haemocompatibility in CVVH—an in vitro study
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.